Blaine A. Pfeifer
- Pharmacology top 0.2%
- Microbial Natural Products and Biosynthesis 52
- Biotechnology top 0.5%
- Molecular Biology top 1%
- Microbial Metabolic Engineering and Bioproduction 34
- RNA Interference and Gene Delivery 19
- Plant biochemistry and biosynthesis 19
- Biomaterials top 5%
- Biomedical Engineering top 5%
-
- Virus-based gene therapy research 14
-
- Pneumonia and Respiratory Infections 10
- Respiratory viral infections research 9
-
- Plant-Microbe Interactions and Immunity 9
- Co-authors
- Chaitan KhoslaYong WangGregory StephanopoulosParayil Kumaran AjikumarWenhai XiaoKeith E. J. TyoFritz SimeonEffendi Leonard
- Journals
- Science (2 papers)Proceedings of the National Academy of Sciences (2 papers)Nature Communications (2 papers)
- Partner nations
- United StatesChinaTaiwan
In The Last Decade
Blaine A. Pfeifer
113 papers receiving 6.1k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Pharmacology 2.2k
- Biotechnology 706
- Molecular Biology 4.9k
- Biomaterials 382
- Biomedical Engineering 942
Countries citing papers authored by Blaine A. Pfeifer
This map shows the geographic impact of Blaine A. Pfeifer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Blaine A. Pfeifer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Blaine A. Pfeifer more than expected).
Fields of papers citing papers by Blaine A. Pfeifer
This network shows the impact of papers produced by Blaine A. Pfeifer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Blaine A. Pfeifer. The network helps show where Blaine A. Pfeifer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Blaine A. Pfeifer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 1 | |
| 4 | 2021 | 1 | |
| 5 | 2021 | 6 | |
| 6 | 2020 | 28 | |
| 7 | 2020 | 8 | |
| 8 | 2019 | 2 | |
| 9 | 2018 | 21 | |
| 10 | 2017 | 21 | |
| 11 | 2016 | 28 | |
| 12 | 2016 | 7 | |
| 13 | 2016 | 21 | |
| 14 | 2014 | 8 | |
| 15 | 2014 | 279 | |
| 16 | 2013 | 2 | |
| 17 | 2011 | 14 | |
| 18 | 2011 | 28 | |
| 19 | Isoprenoid Pathway Optimization for Taxol Precursor Overproduction in Escherichia colibreakdown → | 2010 | 1266 |
| 20 | 2010 | 92 |
About Blaine A. Pfeifer
Blaine A. Pfeifer is a scholar working on Pharmacology, Biotechnology and Molecular Biology, having authored 115 papers that have together received 6.2k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (52 papers), Microbial Metabolic Engineering and Bioproduction (34 papers), RNA Interference and Gene Delivery (19 papers), Plant biochemistry and biosynthesis (19 papers), Virus-based gene therapy research (14 papers), Pneumonia and Respiratory Infections (10 papers), Plant-Microbe Interactions and Immunity (9 papers) and Respiratory viral infections research (9 papers). The work is most often cited by research in Pharmacology (2.2k citations), Biotechnology (706 citations) and Molecular Biology (4.9k citations). Blaine A. Pfeifer has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Chaitan Khosla, Yong Wang, Gregory Stephanopoulos, Parayil Kumaran Ajikumar, Wenhai Xiao, Keith E. J. Tyo, Fritz Simeon, Effendi Leonard, Charles H. Jones and Brett A. Boghigian. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.